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EXPLANATION OF DISSERTATION FORMAT 
This diaacrtation conaiata of a ganaral introduction, a literature 
review, two aeparate nanuacripta, a general concluaion, referencea and 
acknowledgenenta. The nanuacripta are preaented in the format required 
for the diaaertation. 
The Ph.D. candidate, Jane Kwun-Lai Kan Battlea, ia the aenior 
author and principal investigator for each of the nanuacripta. 
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GENERAL INTRODUCTION 
Bovin# adanovirufct (BAVs) have been aasociaead vich pneumonia, 
•ntarltla, pncunoantaritla, conjunccivieif, karacoconjunctivieia and 
weak calf ayndromc (46). At Isaac 10 larotypaa of BAVa arc racognizad 
(46,64) and chay hava baan divided into tvo lubgroupa baaed on antigenic 
and cultural characterlatica (6,64). A garologic eurvey by D. E. Reed 
(personal communication. Molecular Genetics, Inc., Hinnetonka, MN) has 
indicated that BAV-2, -3, -6, -7 and strain 9639 (a probable new serotype) 
are the most common in the Midwestern United States. It is thought that 
some degree of cross-protection exists within a subgroup and that the 
innainologic recall phenomenon acts within a subgroup (6,47,71,88). If 
a vaccine is to be constructed, it must, therefore, include members of 
both subgroups. In this study, BAV serotypes 2, 3 and 7 were chosen to 
represent both subgroups, 
Purified viral subunits were prepared by preparative agarose 
Immunoelectrophoresis, a method which has been used for production of 
monospecific sera to capsid subunits of human adenoviruses (14,15,16, 
28,55). The viral neutralization potentials of the sera produced were 
analyzed using ^  vitro assays. Antigens involved in viral neutralization 
are primarily those associated with the hexon, but fiber antigens 
also have been implicated (67). Since hexon subunits are available 
in large quantities, efforts were concentrated on isolating hexon sub-
units that were capable of inducing viral neutralizing antibodies. 
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Before recombinant DMA technology can be utilized to manufacture 
these subunits, the relative locations of the genes coding for the major 
capsid proteins need to be identified on the genome. Since the genome 
of human adenovirus type 2 (KAV-2) has been well characterized, cross-
hybridisation studies were performed between HAV-2 and BAV-7 DMAs. 
Taken together with previous studies between HAV-2 and BAV-3 (42), the 
genomic homology data made it possible to align the genomes of the BAVs 
to HAV-2, and to study possible evolutionary relationships between these 
viruses. 
The objectives of this study were: 
1) To isolate and identify the immunogenic protein subunits of 
BAY types 2, 3 and 7. Particular attention was paid to the 
hexon subunits. 
2) T6 prepare in rabbits monospecific sera against the isolated 
proteins. 
3) To characterize these monospecific sera using viral neutraliza­
tion, ismnmoprecipitation/sodiuai dodecylsulfaee polyacrylanide 
gel electrophoresis, immunodiffusion and Western blot analysis. 
4) To determine the apparent molecular weights of the major capsid 
polypeptides of BAV-2, -3 and -7. 
5) To locate the relative positions of the genes coding for the 
major capsid proteins on the BAV-7 genome. 
6) To study possible evolutionary relationships between the BAVs 
and HAV-2. 
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LITERATURE REVIEW 
Adtnovlrutas originally ware dlscovarad In human adenoidal call 
culeuras (79) and a# aganca causing rasplraeory infections of military 
recruits (40). The human adenoviruses (KAVs) are known to cause acute 
respiratory illness (40), epidemic keratoconjunctivitis (45) and infantile 
gastroenteritis (30). In addition, sotM HAVs possess oncogenic potential 
in nonpermissive cells (43,86). 
Adenoviruses have been Isolated from a variety of animal species, 
including monkey, cattle, pig, sheep, horse, dog, goat, mouse, opossum, 
tree shrew and birds (92). The first Isolation of an adenovirus from 
cattle vas reported by Klein at al. (49). Bovine Infections frequently 
are Inapparent, but in calves, bovine adenoviruses (BAVs) can cause 
pneumonia, enteritis, pneumoenteritls, conjunctivitis, keratoconjunctivitis 
and twak calf syndrome (46). Only one serotype, BAV-3, is known to be 
oncogenic for newborn hamsters (25). 
Bovine Adenoviruses 
Presently, at least 10 serotypes of BAVs are recognized throughout 
the world (46,64), The BAVs are divided Into two subgroups based on 
cultural and antigenic characteristics (6,64). The BAVs have been reviewed 
extensively (58,64), and their roles in bovine diseases have been 
summarized by Kahrs (46). The prototype strain of each serotype and the 
subgroups of BAVs are shown in Table 1. 
4 
Tabla 1. Bovina adanoviruaaa 
Subgroup Sarocypa* atraln Rafaranca 
Procotypa 
1 BAV-1 10 49 
BAV-2 19 50 
BAV-3 WBRl 27 
2 BAV-4 THT/62 9 
BAV-5 B4/65 9 
BAV-6 671130 76 
BAV-7 Fukurol 44 
BAV-8 Mlak 67 11 
BAV-9 Sofia 4/67 36 
BAV-IO Nagano" 85 
Each aaroeypa of adanovlnia la now daaifnatad aa a apaciaa, 
according to the laeaae report of the International Committee on the 
Taxonomy of Vlruaea (92). 
T^he only example in the literature of ualng atrain Nagano aa the 
prototype atraln of BAV-IO waa found in the croaa-neutralizatlon teats 
performed by Kohanty (64). 
BAV-1 (strain 10) and BAV-2 (atrain 19) were isolated from the feces 
of apparently normal cows upon culturing on primary calf kidney cells 
(49,50). Additional isolates of BAV-1 were reported from nasal samples 
of calves with pneumonia (25), calves with pneumoenteritis (81), normal 
calves (65), and calf kidney cell cultures (29). Additional isolation 
of BAV-2 was reported from embryonic kidney cell cultures as an 
adventitious contaminant (66). Both viruses are widespread among cattle 
populations, as demonstrated by the presence of neutralizing antibodies 
(32,48,49,50,64,77,97). In addition, BAV-2 strains have been found to 
cause natural outbreaks of respiratory diseases among sheep in Hungary 
(12). 
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BAV-3 (strain WBRl) was isolated from the eye of an apparently 
healthy cow upon culturing in bovine kidney cells (27). Additional 
isolates of BAV-3 were reported from a herd with pneuooenteritis (57), 
and cattle with acute respiratory disease (S3). Serologic studies have 
indicated that BAV-3 is prevalent in the United States (13,54,57,64) 
and other countries (32,37). In addition, antibodies to BAV-3 have been 
detected in a herd of goats in Louisiana (31), and BAV-3 has been isolated 
from free-living African buffaloes (4). 
BAV-4 (strain TMT/62) and BAV-5 (strain BA/65) were isolated from 
calves with pneuooenteritis. Upon repeated passages in primary calf 
testicular cell cultures, these viruses were Isolated from bronchial, 
nasal, conjunctival and fecal samples, as well as from a variety of 
tissues (9). Additional Isolates of BAV-4 were reported from bulls with 
pneiowenterltls and respiratory disease (59), unlnoculated bovine testic­
ular cell (10,73), and free-living African Buffaloes (4), In addition, 
neutralizing antibodies to BAV-4 and -5 have been found In cattle 
populations (59,64,73,97). 
BAV-6 (strain 671130) was Isolated as a latent virus from primary 
calf testicular cell cultures (76). Additional Isolates of BAV-6 Include 
strain RC from calves with pneumonia (20,21), and strain KC-2 from cattle 
with keratoconjunctivitis (93). Serologic surveys by Mohanty (64) and 
Cole (22) Indicated the presence of neutralizing antibodies by BAV-6 in 
cattle populations. 
The prototype strain of BAV-7, strain Fukorol, along with 8 other 
strains, was isolated from the blood, feces and viscera of cattle with 
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acute reapiratory diaeaae upon culeurlng In primary calf teaticular 
cella (44,60). Additional laolatlona of BAV-7 were reported from 
tiaauea and fecea of calvea with pneumonia and enteritia (75)» blood 
and aynovlal fluid of calvea with weak calf ayndrone (23,62,84), and 
bovine teaticular cell culturea aa an adventitioua agent (73). Although 
large acale aerologlc aurveya of BAV-7 have not been performed, the role 
of BAV-7 aa an etiologic agent haa been eatabliahed (44,62,73). In 
addition, BAV-7 haa been reported to cauae abortion experimentally (83). 
Recently, antibodiea to BAV-7 were found in apparently healthy goata in 
Louiaiana (31). 
BAV-8 (atrain Miak 67) waa iaolated from calvea with pneumoenteriti# 
(11). Another atrain of BAV-8 waa iaolated from a cow with leukoaia (61). 
A aerologlc aurvey indicated that BAV-8 la prevalent in the cattle 
populatlona In Hungary (63). BAV-8 alao haa been Iaolated from free-living 
African buffaloea, along with BAV-3 and -4 (4). 
BAV-9 (atrain Sofia 4/67) waa iaolated from kidney and teaticular 
cultures of healthy cattle (36,37). Additional isolation# of BAV-9 
include strain BIL from calves with pneumonia (20,21) and strain KC-6 
from cattle with conjunctivitis (93). 
BAV-10 (strain Nagano) was Isolated from blood specimens of calves 
with mild respiratory disease upon culturlng in primary calf testicular 
cells (85). Other probable new serotypes of BAV Include an European 
strain Isolated from cattle with pneumonia (51), a New Zealand strain 
Isolated from a yearling heifer with systemic infection (41), and strain 
9639 from South Dakota (D. E. Reed, Molecular Genetics, Inc., 
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Minnstonka» personal communication). 
Adenovirus Nomenclature 
The family Adenoviridae is divided into two genera, Mastadenovirus 
(mammalian adenoviruses) and Aviadenovirus (avian adenoviruses). This 
grouping originally was proposed because of the absence of immuno­
logically cross-reactive proteins (92). Most adenoviruses isolated from 
mammalian hosts share a soluble complement fixation antigen (78). A 
notable exception to this is represented by the members of BAV subgroup 2 
(6). Therefore, these serotypes are identified as adenoviruses based on 
their morphology, nature of nucleic acid content, aid other physiochemical 
properties such as resistance to ether and chloroform (64). 
The KAV species (formerly serotypes) have been classified into 
5 subgenera (formerly subgroups) with respect to their biophysical, bio­
chemical, biological, and immunological characteristics (92). Each 
adenovirus specie# is defined "oa the basis of its immunological distinc­
tiveness, as determined by quantitative neutralization with animal anti-
sera. A species has either no cross-reaction with others or shows a 
homologous-to-heterologous titer ratio of >16 in both directions" (92). 
Bovine adenovirus subgroups 
The BAVs have been divided into two subgroups, based on antigenic 
and cultural properties (6,64). Maubers of subgroup 1 replicate in both 
bovine kidney and testicular cell cultures and possess the common soluble 
antigen present in Mastadenovirus. Members of subgroup 2 share only 
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crac*#, if any, of eha common aolubla antigen of the genua. Thasa 
viruaas are grouped on the basis of their failure to grow in bovine 
kidney cell cultures and their slow propagation rate in bovine teaticular 
and lung cultures. Isolation of subgroup 2 BAVs often requires a series 
of blind passages. Characteristic differences in cytopathic effect also 
are observed between the two subgroups. Subgroup 1 viruses usually 
induce a single nuclear inclusion, irregular in shape, while subgroup 2 
viruses form mainly multiple inclusions that are regular in shape. In 
addition, members of subgroup 2 are partially resistant to inactivation 
at 56°C for 30 minutes (6). 
Recently, Adair and Curran (1) proposed a slightly different sub-
grouping of BAVs based on detailed studies on the cytopathology in cell 
cultures. Using Immunofluorescence, electron microscopy, and Haemacoxylin 
and Eosin cytology studies, they divided the BAVs into two subgroups with 
BAV serotypes 1, 2, 3, 7 and 9 in on# subgroup and serotypes 4, 5, 6 and 
8 in the other. 
Although members of subgroup 2 do not share the soluble complement-
fixation antigen with other mastadenoviruses* cross-reactions using other 
immunologic methods have been reported. Using the double immunodiffusion 
test, some workers reported cross-reactions (4,21) while others reported 
no cross-reactions (2,19,73,85). Using cross-fluorescent antibody tests, 
sharing of antigens was demonstrated between BAV subgroup 2 (BAV-5, -7, 
-8) and conventional mastadenoviruses (BAV-l, 2; HAV-2, -5) by Adair 
et al. (2). However, Hohanty (64) reported the lack of cross-reactions 
using the same tests. In addition, antibodies to BAV-7 have been 
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reported to neutralixa KAV-11 (96). 
Subgroup» baaed upon polypeptide pattema 
Moat criteria uaed for grouping adenoviruaea, auch aa hemagglutina­
tion and oncogenicity, are baaed on properties representing only minor 
regiona of the genome. The atructural polypeptidea of the virion, 
however, repreaent a major portion of the adenovirua gene producta (34). 
Sodium dodacylaulfate polyacrylamide gel electrophoreais (SOS PACE) 
analyaia of different KAV aubgroups have ahovn that members of a aubgroup 
ahare an apparent molecular weight pattern for the internal atructural 
polypeptidea. However, each aerotype diaplaya an unique pattern for the 
capsid polypeptides 11, 111, Ilia and IV (hexon, penton baae, peripentonal 
area and fiber, respectively). This makes 9)S PACE a useful tool in 
confirming the identification of a serotype and for the subgroup classi­
fication of adenoviruses (89). 
Genomic homology studies 
The ultimate subgroup classification will be based on nucleotide-
sequence differences between the genomes of different serotypes (90) 
because the evolution of a virus is the direct result of gradual changes 
in the nucleotide sequence of the genome (3). Extensive sequence homology 
studies of BAVs have been performed (33,34,35). Genomic homology studies 
between HAVs and adenoviruses of animal origin have been performed by 
several groups of investigators. Larsen et al. (52) found two distinct 
regions of homology between HAV-2 and mouse FL at 11.2-14.9 map units 
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(m.u.) and 51.6-62 n.u. on the KAV-2 gonosM» corresponding to Che 
lVa2- and hexon-coding gene#, respectively. Studies between bovine 
subgroup 1 and HAV-2 showed even more homology. Niiyaoa et al. (68) 
reported 25% homology between BAV-3 and HAV-S, while Hu et al. (42) 
showed 80% homology between BAV-3 and KAV-2. Homology studies between 
avian and human adenoviruses also have been performed. Alestrom et ai. 
(3) found two distinct regions of homology between fowl adenovirus type 1 
(CEIO virus) and KAV-2 at 18.1-19.3 m.u. and 57-38 m.u. The first region 
does not correspond to any gene recognized so far, but the second region 
is within the hexon gene. Therefore, homology exists between the genomes 
of these two viruses even though avian and human adenoviruses do not 
cross-react serologically. Since structural constraints dictate certain 
similarities in the amino acid sequences of the hexon proteins from 
different adenoviruses, at least part of the hexon gene should be conserved 
in order to generate a capsid protein which can give rise to the 
characteristic adenovirus architecture (3). 
Antigenic Determinants 
The capsid components of adenoviruses display a wide range of anti­
genic specificities. Bacons carry group, intersubgroup, intrasubgroup 
and type specificities (70). Penton bases carry group* intersubgroup 
and intrasubgroup specificities (91). The fibers carry intersubgroup, 
intrasubgroup and type specificities (69). 
The capsid subunits of adenoviruses are produced in excess by the 
infected cell as soluble antigens. This has facilitated the purification. 
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characterization and immunological identification of the virus capsid 
subunlts (72), Crossed immunoelectrophoresis (CIE) has been used 
successfully to detect, identify and quantitate major HAV-2 soluble anti­
genic components (14,15,28,55,36). The CIE pattern of KAV-2 is comprised 
of 5 major peaks of immunoprecipitates. From the anodic to the cathodic 
side of the gel, they are: the hexons, free penton base, fiber deter­
minants of pentons, penton base determinants of pentons, and the free 
fibers. The fiber and penton base determinants of pentons co-migrate, 
thus forming "stacked" peaks on the gel (56). CIE patterns are useful 
for the characterization of ts mutants with structural alterations, and 
for analyzing monospecific sera from animals immunized with agarose 
immunoprecipitates of subunies (16,55,56). 
Vaccines 
A subunit vaccine contains only the necessary viral structural 
components (subunlts) required Cor eliciting a protective immune response 
(74,80). The development of adenovirus subunit vaccines free of any 
trace of nucleic acids is very important because of the oncogenic 
potential of some adenoviruses (26,80). 
HAV subunit vaccines 
Experimental subunit vaccines in human trials have been reviewed by 
Neuratb and Rubin (67). The hexon and fiber subunlts have been isolated 
in crystalline form from purified HAV-5 (39) and have been shown to 
induce protective immnity in humans (24). Analysis of purified hexons 
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and fibara of KAV-2 and -5 haa ahovn Chat only typa-apacific antigenic 
datarminanta ara activa in atiaulating nautralixing antibodiaa (94,93). 
Fibar antigana of aavaral HAV typaa hava baan ahovn to induce viral 
neutralizing (VN) antibodiaa in human voluntaera, but conflicting raaulta 
have been reported concerning the formation of VN antibodiaa in experi­
mental animala immunised with fiber antigana. In addition, the antibody 
reaponae experienced in the human volunteers appeared to be aubgroup-
apecific, but a type-apecific VN antibody response vaa found in the 
experimental animale. One explanation for this could be aacribed to 
possible previous «cposure of the adult voluntaera to adenoviruses, so 
that the fiber antigen immunization induced a secondary response (67). 
BAV vaccinae 
Inactivated and modified live BAV vaccines have been used in some 
European countries, but they have not gained acceptance in North America 
(46). Experimental BAV vaccines have been summarized by Burki (17). 
Inactivated BAV vaccines have been produced against individual serotypes 
(5,17,18), in a combination of serotypes (7,8), and in multicomponent 
vaccines with parainfluenza -3 (82,87), and with both parainfluenza-) 
and reovinis (82). Modified live BAV vaccines have been produced with 
attenuated BAV-4 (5), and trith a ts mutant of BAV-3, in combination with 
parainfluanza-3 and infectious bovine rhinotracheitis in a trivalent 
vaccine (98). In addition, the use of hyperimraine senm as a prophylactic 
measure has been investigated (38). Although serologic responses were 
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noted in tha vaccinated animale, the protection conferred by these 
vaccines upon challenge with BAVs have not been studied. 
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PART %. ISOLATION AND EVALUATION OF THE IMMUNIZING SUBUNITS OF BOVINE 
ADENOVIRUS TYPES 2, 3 and 7 
This n4mt9çripe ha# been suboieeed for publication to Veterinary 
Microbiology. 
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ISOLATION AND EVALUATION OF THE IMMUNIZING SUBUNITS OF BOVINE 
ADENOVIRUS TYPES 2. 3 and 7 
J. K. Battle# 
D. E. Read 
From tb« Veeerituiry Medical Research Xnaeicute, Iowa State University, 
Anes, lova 50011. 
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ABSTRACT 
Monospecific ssra against protein subunlts of bovine adenovirus 
(BAV) types 2» 3 and 7 were produced in rabbits, using agarose immuno-
preeipitates prepared by preparative Immunoelectrophoresis, Various 
forms o( solubillxed viral antigens were separated in line or crossed 
Immunoelectrophoresis using type-specific hyperimmune sera. The specifi­
cities of these sera were determined by icmunoprecipitation/sodium 
dodecylsulfate polyacrylamide gel electrophoreaia (IP/SOS PAGE)» Western 
blot and immunodiffusion. The viral neutralization potentials of these 
sera were analyzed using in vitro tests in homologous and heterologous 
systems. Since both viral neutralizing and non-neutralizing mono­
specific sera to hexons were obtained, a peptide mapping system using 
limited proteolysis in SOS PACE was employed to detect any differences 
that may be present in the hexon polypeptides precipitated in IP/SOS 
PACE. In addition, BAV-3 hexon subunlts, produced by deoxycholate and 
heat treatment followed by DEAE BioCel A chromatography, were used to 
produce hyperimmune sera. These anei-hexon sera seemed to be superior to 
the monospecific sera produced from agarose inmunoprecipitates in that 
they possessed subgroup-reactive neutralizing activities in addition to 
type-reactive ones. The presence of hexon subunlts capable of inducing 
both subgroup- and type-specific viral neutralizing antibodies makes 
this subunit preparation an ideal candidate for use in a multivalent 
subunit vaccine. 
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INTRODUCTION 
Adanovirusea ara non-«nvalop«d» doubla-strandad DMA virus##. Th# 
viral partiel# conaiat# of an icoachadron* 70-90 nm in diam#c#r, vich 
2S2 capflooar#. Of ch###, 240 ar# eh# ncn«v#re#x cap#om#r#« or h#xon#, 
and 12 ar# eh# v#re#x capsoncra» or paneon basas. Eiehsr 1 or 2 fib#rs 
ar# aetachad eo #ach paneon basa, d#p«nding on eh# g#nus of adanovirus## 
(37). Zn human#, adenovirus## ar# associaead wieh raspiraeory (13), 
ocular (14) and gaaeroineaseinal infaceions (11). In addieion, some human 
adenovirus## (HAVs) ar# oncogenic in non-permissive cells (31). 
Bovine adenoviruses (BAVs) are associaead wieh pneumonia, eneerieia, 
pneumoencerieis, conjunceivieis, keracoconjunceivieis and weak calf 
syndrome. Only one seroeype, BAV-3,has been shown eo be oncogenic for 
newborn hamaeers (9). There are ae lease 10 seroeypes of BAVs (15,24), 
which are divided ineo ewo subgroups based on culeural and aneigenic 
characeeriseics (2,24). BAY eypea 1 ehrough 3 are in subgroup 1 while 
BAV eypea 4 ehrough 7 are members of subgroup 2. 
A serologic survey by 0. E. Reed, personal communicaeion. Molecular 
Ceneeica, Inc., Kinneeonka, HSf) haa indicaeed ehae BAV-2, -3, -6, -7 
and serain 9639, a probable new serotype, are ehe mose common in the Mid­
western United States. Other serologic surveys also have documented the 
prevalence of BAVs in the cattle populations in this country (3,17,20,23, 
24). It is thought that some degree of cross-protection exists within 
each subgroup and that the Immunologic recall phenomenon acts within a 
subgroup (2,16,28,32). If vaccines are to be constructed, they must. 
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therefor*, include member# of both eubgroup#. BAV type# 2, 3 and 7 
were cho##n for thi# #tudy becauae they are common in the United State# 
and represent both subgroup*. 
Ad#noviruae# elaborate a complex #«rie# of antigen apecificitie#. 
H#xon# carry group, interaubgroup, intraaubgroup and type apecificitie# 
(27). Penton baaea carry group, interaubgroup and intraaubgroup apeci­
ficitie# (35). The fiber# carry interaubgroup, Intraaubgroup and type 
apecificitiea (26). Analyaia of purified HAV hexon and fiber aubunit# 
ha# shown that only type-apecific antigenic deteroinanta are active in 
atimulating neutralizing antibodie# (38,39). 
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MATERIALS AND METHODS 
Cell Culture 
BAV-2 and -3 were propagated on Madin Darby bovine kidney <MDBK) 
celle. BAV-7 wae propagated on low paeeage bovine lung (BLC) celle; 
KAV-2 wae grown on HeLa celle. BAV-2, -3 and -7 reference etraine were 
obtained from the American Type Culture Collection (ATCC), RockviUe, 
KD. WAV-2 and HeLa celle were provided by Dr. S.-L. Hu (Molecular 
Genetice, Inc.). Celle were grown in Eagle'e minimum eeeential medium 
with Earle'e ealte (MEM) eupplemented with 10% betapropiolactone-treated 
fetal calf eerum (FCS), 0.16% aodium bicarbonate, 8 oM R-2-hydroethyl-
pipar8zine-N*-2-ethaneeuifonic acid (HEFES), 0.2% lactalbumin hydrolysate, 
2 mM L-glutamine and 62.7 ug per ml of ampicillin (eodium ealt). Cell 
cultures were grown and maintained at 37*C in a humidified air atmosphere 
containing 2% carbon dioxide (CO^ ). 
Virus Stocks 
All virus strains were passaged three times, as described below, 
prior to usage for antigen production. Cell cultures were infected at 
a multiplicity of infection (MOD of 0.1 median tissue culture infective 
doses (TCID^ g) per cell. Infected cultures were maintained as described 
for all cultures except the MEM was supplemented with 5% FCS. When maximum 
cytopathic effect (CPE) was evident, infected cultures were harvested, frozen 
and thawed 3 times, and centrifuged at 600 X g for 10 minutes. The supemate 
was extracted with one tenth volume of chloroform, followed by low speed 
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ccntriCugation (600 X g, 10 minuces). The virus-containing aqueous phase 
vas scored in aliquot# at -70°C. 
Virus stocks were titrated in aicrotitration plates, using tenfold 
virus dilutions. Endpoints were determined on the basis of CPE develop­
ment in unstained cultures <BAV-2, -3, HAV-2), or upon nuclear inclusion 
body formation in Ciemsa-stained cultures <BAV-7). Titers were calculated 
by the Reed and Muensch method (30) and expressed as TCID^ q per ml. 
Antigen Preparation 
Monolayers of cells were infected at a MOl of 3 to 5 TCIO^  ^per cell. 
Infected cultures were maintained in MEM supplemented with 5Z FCS. 82 ug 
per ml of gentamycin sulfate, 62.7 ug per ml of ampicillin, 10 ug per ml 
of amphotericin B, and incubated as described for cell cultures. At 
maximum CPE, cultures were harvested and clarified by low speed centrifuga-
tion. The pellets were used for preparing cell lysates and cell-associated 
virions; the supernatant fluids were used for partially purified virions 
and soluble antigens. Both cell-associated virions and partially purified 
virions were used for preparing purified virions and hexons. The various 
antigen preparations used in this study are shown in Figure 1 and described 
below. 
Cell lysates 
Infected cell pellets were resuspended in lysis buffer (lOnM Tris-
HCl, pH 7.4, IfflH EDTA, 0.1 M NaCl, 0.5%, w/v, sodium deoxycholate, 1%, 
v/v, Nonidet F-40), placed on ice for I hour, and centrifuged at 13,000 Xg 
for 15 minutes. The supemates were designated as "cell lysates". 
Figura 1. The various ancigsn préparations usad in this study. 
Raagants and axparimantal conditions ara dascribad 
in tha taxt 
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Call-aaaoclatad virions 
Infacted call pallets %far# resuapendad in a buffer containing 30 mM 
Tris-HCl. pH 7.5. 0.5 mM EDTA, 0.5% (v/v) Konidat P-AO (K7-40) and 6 mM 
2-marcaptoathanol, extracted with Freon at one-tenth the sample volume, 
and centrifuged at 350 X g for 5 minutes. The aqueous phase was centri-
fuged through a atep gradient consisted of equal volmnes of 5 and 45% 
glycerol (v/v in 30 mM Tris-HCl, pH 7.5) at 100,000 X g for 1 hour at 4^ C. 
The pellets were resuspended and dialyzed in TE buffer (10 mM Tris-HCl, 
pH 8.0, 1 mM COTA), and designated as "cell-associated virions". 
Partially purified virions (PPV) 
PPV antigens were prepared by centrifuging culture supernatant fluids 
through 40% sucrose (w/v in 0.2 M phosphate buffer, pH 7.4) at 100,000 Xg 
for 1 hour at 4*C. The pellets were resuspended in 10 mM Tris-BCl, pR 7.4, 
and designated as "PPV" antigens. 
Saturated ammonium sulfate precipitation of soluble antigena 
Soluble antigens were purified by a method adapted from Boulanger 
and Puvion (5). After the culture supernates were centrifuged through 
40% sucrose, the MEM and sucrose fractions were collected separately and 
dialyzed against IE buffer. The samples were adjusted to a final concentra­
tion of 55% with saturated ammonium sulfate (SAS), pB 6.8. The precipitates 
were stirred for 18 hours at 4°C and collected by centrifuging at 2,000 Xg 
for 30 minutes. The pellets were resuspended and dialyzed in 0.025 M 
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Trl«-Trlcln« buffer (4.3 g/1 Trle-HCl. pH 8.6, 9.8 g/1 Trlclna, 0.11 g/1 
calcium lactate and 0.2 g/1 scditm aside) containing 0.15 M KaCl (TIN 
buffer). These were designated as SAS/MEM and SAS/sucrose soluble antigens, 
respectively. 
Purified virions 
Virions were purified further from cell-associated virions or PPV 
preparations using two cycles of cesium chloride (CsCl) gradients. 
Samples were layered onto a preformed step gradient (p«1.2 and 1.4 in 
10 mM Tris-RCl. pH 7.4), and centrifuged at 100,000 X g for 1 hour at 4*C. 
The virus bands were collected and subjected to isopycnlc gradient centri-
fugation (p»i.3) at 100,000 Xg for 18-20 hours at 4*C. Virus bands were 
collected and dialyzed against TE buffer, pH 8.0. 
Hexons 
Rexons were purified from cell-associated virions or PPV antigens 
using a method adapted from Pereira and Wrigley (29). The antigens were 
dialyzed against 5 mM Tris-HCl, pH 8.6, incubated at S6^ C for 3 minutes 
in the presence of 0.5% (w/v) sodium deoxycholate (DOC), and purified by 
OEAE Bio Gel A chromatography (Bio Bad Lab., Richmond, CA). The column 
was equilibrated against 5 mM Tris-BCl, pB 8.6, and eluted using buffers 
of increasing ionic strength (0.05 M, 0.1 H, 0.2 H, 0.3 H and 2 H NaCl 
in 5 mM Tris-HCl, pH 8.6). Fractions eluted were monitored by conductivity 
and by absorbance at 280 nm. Protein-containing fractions were pooled, 
concentrated using YM 10 membranes (Amicon Corp., Danvers, MA), and 
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analyzed on SDS PAGE (me* IP/SDS PACE below). Protein concentrations 
were determined a# described by Bradford (6). 
Hyperimmune Type-Specific Antisera 
Calf reference antisera 
Reference antiserum for BAV-2 (C87) was prepared in a colostrum-
4 deprived calf. One ml of chloroform-treated stock (10 TCIO q^) was 
emulsified in an equal volume of Freund's incomplete adjuvant (FIA), and 
injected intramuscularly (XM) on days 1, 21 and 36. Blood was collected 
10 days after the last injection. 
Reference antisera for BAV-7 (C72) and strain 9639 (CCIO) were 
prepared in a colostrum-deprived calf and a gnotobiotic calf, respectively, 
by J. G. Wheeler (Iowa State University. Ames, lA). For C72, ATCC BAV-7 
stock was injected intravenously (IV) on day 1. followed by IM injections 
of a FIA-emulsified BAV-7 field Isolate on days 14 and 17. For CCIO, 
chloroform-treated strain 9639 stock was injected IM on day I, followed 
by an IM injection of a FIA emilsified stock on day 21. 
Rabbit reference antisera 
Reference antiserum for BAV-3 (RJ4) was produced in a rabbit using 
bexon subunits. Approximately 20 ug of BAV-3 hexons were emulsified In 
1 ml of FIA and injected IM on days 1, 21 and 28. The rabbit was 
exsanguinated for serum one week later. 
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In addieion, CaCl-purifi«d virions were used eo produce cype-
apecitie aera. The cop (incomplete viriona) and bottom (complete 
virions) banda of a BAV-3 CaCl isopyenic gradient were used to inoculate 
rabbita RJ39 and RJ40, reapectively. Similarly» top and bottom banda 
of a BAV-7 CaCl isopycnic gradient were used for rabbits RJ44 and RJ43. 
respectively. All four rabbita were immunised uaing the same methods 
and schedule employed for RJ4, 
Reference aera for KAV-2 (R106 and R107) were provided by Dr. 
S.-L. Ku (Molecular Genetics* Inc.). Briefly, KAV-2 stocks and Freund's 
complete adjuvant (FCA) were uaed for IH inoculations of both rabbits. 
Globulin Precipitation 
The globulins from antisera were prepared by saturated ammonium 
sulfate (SAS) precipitation according to Garvey et al. (12). Globulins 
were precipitated at SAS (pH 7.8), stirred overnight at 4^ C. and 
centrifuged at 2,000 Xgfor 30 minutes. The pellets were resuspended 
in TIN and subjected to 2 more cycles of SAS precipitations. The final 
pellets were resuspended at one half the original sangle volume, dialyzed 
extensively against TTN, and designated as "antibodies". 
Monospecific Antisera Production 
Monospecific antisera to BAV subunlts were produced in rabbits using 
agarose Immunopreclpltates prepared by preparative lonmnoelectrophoresis. 
All Immunopreclpltates were prepared by line Immunoelectrophoresis (LIE) 
except for the ones used in rabbits RJ 1-3, 11, 12, 14-16, which were 
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prepared from crossed inmunoeleccrophoresis (CIE) gels. The various 
antigens used in preparing Che inmunoprecipicates are shown in Table 1. 
In some instances, intermediate gels were used in LIE to facilitate the 
separation of antigen subunits. Inocula for rabbits RJ 37. 38, 42, 43, 
46-48, 34-60 were prepared from iomunoprecipitates using intermediate 
gels. 
The rabbits were purchased from 2 local commercial sources. Rabbits 
RJ 1-3, 9-13 were obtained from one source while rabbits RJ 4-8, 14-60 
were obtained from the other source. Each inmunoprecipitate from an 
unstained gel was divided into 3 equal portions and stored in 0.5 ml of 
TT buffer. In the case of CIE gels, arcs from duplicate plates were used. 
The inoculum was emulsified in an equal volume of FIA and was injected 
IN on days 1, 21 and 28. The rabbit was exsanguinated for blood a week 
later. Antibodies were prepared from the serum using the globulin precipi­
tation method described above. 
The progress of the immunization was monitored by rocket Immuno­
electrophoresis. The final antibodies were characterized in CIE using 
the monospecific antisera as intermediate gels (1). In addition, viral 
neutralization, immunodiffusion, IF/SOS PACE and Western blot techniques 
were used to characterize each antisera. 
Crossed Immunoelectrophoresis (CIE) 
Crossed immunoelectrophoresis was performed as described by Vestergaard 
(33) and modified by Lum and Reed (21). The agarose gels consisted of 
1% agarose (Standard Low M^ , Bio Rad Lab.) in TT buffer containing 1% 
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Tabic 1. The antigans usad in preparing inmunopracipitatas for 
fflcnospacific aara production 
Antigan preparations Rabbit numbers (RJ) 
Sucrose pelleted culture supernatant 1, 2, 3. 9. 
(PPV) in 5% NP-40 10, 26. 27 
Sucrose pelleted culture supernatant 7» 1. 11 12 !, 
(PPV) in 0.5% DOC* 14, 15. 16 
DEA£ ion-exchange colusm purified 5. 6. 22. 23 
hexons in 5% NP-40 
Saturated ammonium sulfate 13. 17. 18. 19 
precipitated soluble antigens 20. 21. 24. 28. 
prepared from MEM fractions 33. 34, 35. 36, 
after pelleting through sucrose 37. 38. 42. 43, 
(SAS/KEN in 5% RP-40) 46. 47. 48 
Saturated ammonium sulfate precipitated 25. 29. 30. 31, 
soluble antigens prepared from 32 
sucrose fractions after pelleting 
through sucrose (SAS/sucrose in 
5% SP-40) 
Cell lysates in iZ NP-40 49. 50. 51. 52, 
53. 54, 55. 56, 
57, 58, 59. 60 
P^V antigens vere solubilized hy heating at 56°C for 3 minutes in 
the presence of 0.5Z deoxycholate. 
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each of Triton X-100 and PEG 6000 (TTT buffer). First dimension 
electrophoresis was performed on solubiliied antigens at 10 V/co for 
90 minutes at 10*C. In the second disMnsion, the separated antigens were 
eiectrophoresed into agarose containing 5-20% antibodies, using 1.5 V/cm 
for 18 hours at 10°C. Gels were washed extensively in 0.1 M MaCl, pressed 
dried, and stained with Coomassie Blue R-250. 
Line Immunoelectrophoresis (LIE) 
Line Immunoelectrophoresis was performed according to Krdll (18). 
The solubilised antigens were mixed with Sea Plaque agarose (1% final 
concentration, PMC Corp., Marine Colloids Div., Rockland, ME), placed 
into a trough, and eiectrophoresed into agarose (same as CIE agarose) 
containing 10-20% antibodies. Electrophoresis was carried out at 
1-5 V/cm for 18 hours at 10®C. 
Rocket Immunoelectrophoresis 
Rocket Immunoelectrophoresis was performed according to Weeke (36), 
using the same agarose and conditions as described for LIE. The gels 
were processed for staining as described for CIE. 
Immunodiffusion (ID) 
Double diffusion was performed using the same agarose as for CIE. 
Cell lysates were solubilized in 5Z NP-40 and placed in the center well: 
antibodies were placed in the peripheral wells. Precipitin bands were 
allowed to develop for 48 hours at 25°C inside a humidity chamber. 
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The gels were processed for staining as described for CIE. 
Viral Neutralisation (VH) 
The ability of each antiserum to neutralize homologous and 
heterologous serotypes was assayed by a constant virus-varying antibody 
test VK tests were performed in microtitration plates, using 100 TCID^ Q 
of virus and 0.1 ml of twofold dilutions of heat-inactivated (S6°C, 
30 minutes) serum per well. The tests were carried out to the 1:65,536 
dilution for the homologous virus, and to the 1:256 dilution for heterolo­
gous viruses. W titers were expressed as the reciprocal of the last 
dilution of antiserum showing CPE inhibition. 
Inmnmoprecipitation/SDS Polyacrylamide Gel Electrophoresis 
Badiolabeling of virus 
2 
Infected and mock-infected cultures in 75 cm T-flasks were labeled 
with -methionine at 32 hour postinfection. The culture fluids 
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were replaced with 100 uCi of S)-methionine (1200 Ci/mmol, Amersham 
Corp., Arlington Heights, XL) in 5 ml of methionine-deficient HEM and 
incubated for 2 hours at 37®C. The cultures were fed with 10 ml of 
methionine-deficient HEM and incubated until 72-96 hours postinfection. 
The cultures were harvested and processed for cell lysates and PPV 
antigens. 
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Inanunopracipj tat ion (IP) 
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S-sMthionin« labeled antigen* were solubilized in SX NP-40 and 
incubated with 10-2S ul of antibodies overnight at 4°C. The immune 
complexes formed were adsorbed onto 0.01 mg of Protein A Sepharose 
CL-4B beads (Sigma Chem. Co., St. Louis, MO) by incubating for 1 hour 
at 2S°C. Sepharose beads were pelleted by centrifuging for S minutes 
at 13,000 X g and washed 3 times with TT buffer. The final pellet was 
dissolved in SO ul of SDS PACE treatment buffer (0.125 mM Tris-HCl, 
pH 6.8, 4% SDS, 20% glycerol, 10% 2-mercaptoethanol) and heated for 
2 minutes at lOO^ C. 0.05% bromophenol blue was added as tracking dye. 
SDS PAGE 
SDS PAGE was performed according to the discontinuous buffer system 
described by Laemmli (19). Samples were electrophoresed on 1.5 mm thick 
vertical slab gels (10% acrylmlde, 2.7% K-N'-methylene-bis-acrylamide 
cross-linker) for 3 hours at 35 mA per gel. Molecular weight standards 
(Pharmacia Fine Chem., Piscatsway, tU) were co-electrophoresed on each 
gel. Gels were stained with Coomassie Blue R-250, destained, and dried. 
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For S-methionine labeled proteins, gels were subjected to fluorography 
(7) before drying. Autoradiography was performed at -70*C using Kodak 
XAR-5 film. 
Peptide Analysis 
Peptide analysis by limited proteolysis in SDS PAGE was performed 
according to Cleveland et al. (S). Bands of Interest were cut out from 
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a 10% SDS PACE gal and placed into tha wells of another SDS PACE (15%) 
gel, along with 50 ug of aureua V8 protease (Miles Scientific, 
Haperville, XL). Electrophoresis was carried out as described for SOS 
PAGE except the current was turned off for 30 minutes, when the tracking 
dye was near the bottom of the stacking gel, to allow for proteolysis. 
Gels were processed for autoradiography as described for IP/SOS PACE. 
Western Blot Transfer 
After SOS PAGE, gels were equilibrated in transfer buffer <0.023 M 
Sodium phosphate buffer, pH 6.8). Electrophoretic blot transfer was 
performed as described by Lum and Reed (21). After transfer, the nitro­
cellulose filters were cut into 1 cm strips and processed by 1 of the 
following methods. 
Method JL 
The nitrocellulose filters were processed and incubated with test 
antibodies as described by Lum and Reed (21), using the Tris-saline/BSA 
method. The bound antibodies were detected by the addition of 10 uCi of 
125 
C Il-Protein A (10 uCi/ug, New England Nuclear, Boston, MA). 
Method 2 
The nitrocellulose filters were processed as in Method 1 except 
0.05% Tween 20 was used instead of BSA as a blocking agent. The bound 
125 
antibodies were detected by adding 50 uCi of [ l)-goat F(ab')2 anti-
rabbit IgG (10 uCi/ug, New England Nuclear). When calf antibodies were 
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uf«d» th« strips were incubated first with rabbit anti-bovine IgG 
125 (Cappel Lab., West Chester, PA), followed by the ( l]-goat anti-
rabbit IgG incubation. 
Autoradiography 
Data were analyzed by direct autoradiography at -70*C, using Kodak 
XAR-5 film and an intensifying screen. 
34 
RESULTS 
Type-Specific Reference Sera 
Using viral naueralizacion (VN) tests, none of the anti-BAV sera 
reacted to HAV-2 (Table 2). However, the KAV-2 antiserum, reacted to 
BAV-3. There ware low level cross-reactions between the anti-BAV sub­
group 1 sera and heterologous BAVs. The BAV-7 antiserum did not react 
with any of the subgroup 1 BAVs. 
Hexons 
Figure 2a shows the DEAE BioGel A column profile of BAV-3 hexons. 
Fractions under the two peaks labeled "hexons", as determined by SDS 
PAGE (data not shown), were used to immunize rabbit RJ4. Figure 2b 
shows the crossed immunoelectrophoresis (CIE) patterns of BAV-7 PPV 
antigens before and after deoxycholate and heat treatment, and after DEAE 
ion-exchange chromatography. 
Monospecific Sera Against BAV-2 Subunite 
The various sera produced from iimuinlzing rabbits using agarose 
imminoprecipitatee of BAV-2 subunite are shown in Table 3. Both VH positive 
and negative antisera were obtained. Eight antisera were monospecific to 
hexons, with five showing VN titers of ^ 64. BJ19 and SJ48 were essentially 
monospecific with additional weak reactions to the "300K" polypeptides. 
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Tabla 2. The cross-neutralization titers of type-specific reference 
sera 
Virus 
Antiserum 
(Specificity) BAV-2 BAV-3 BAV-7 HAV-2 
C87 
(BAV-2) 
8,192 16 8 <2 
IU4 
(BAV-3) 
8 32,768 256 <2 
C72 
(BAV-7) 
<2 <2 32,768 <2 
#06* 
(HAV-2) 
2 256* <2 256® 
Both homologous and heterologous VN assays for R106 were carried 
out only to 1:256. Data from plaque-reduction assays (S.-L. Ku» Holecular 
Genetics, Inc.) showed titers of >5,000 and >3,000 against HAV-2 and BAV-3, 
respectively. Preinoculation sera were negative. IP/SOS PAGE showed 
that Ri06 is type-specific to HAV-2 because it did not react with BAV-3 
fiber. It is not known why R106 possesses VN or plaque-reduction titers 
to BAV-3. 
Figura 2a. DEAE BioGal A column chromatography after daoxycholate 
and heat treatment of BAV-3 cell-aaaoclated virions. 
Column elution vas monitored by conductivity (as indicated 
by the molarities of NaCl), and by the presence of proteins 
(as Indicated by absorbance at 280 nm) 
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Figure 2b. CIE patterns of BAV-7 PPV antigens used for isolation of hexon subunits 
Antibodies: C72, reference antibody 
Antigens: (A) PPV antig^ s before treatment 
(B) PPV antigens after treatment 
(C) Hexons fractions after DEAE BioGel A column purification 

Tabla 3. VN citer* and probable «pecificities of rabbit antiaara 
produced from inmunoprecipitatca of BAV-2 aubunits 
Gel No. 
Antigen 
preparation Antibody 
Intermediate 
gel antibody 
Method of 
separation 
1 PPV C87 LIE 
2 SAS/MEM C87 - LIE 
3 SAS/MEM C87 LIE 
4 SAS/Sucroae RJ9 - LIE 
5 SAS/MEM MIO - LIE 
6 SAS/MEM RJIO - LIE 
7 SAS/MEM IU9 LIE 
8 SAS/MEM C87 IU31 LIE 
9 Cell lysates C87 RJIO LIE 
10 Cell lysates C87 RJ31 LIE 
e^cipitin lines in ilE were lettered from the anodic side of gel. 
S^tandard adenovirus SOS PACE nownclature was used; (II) Bexon; 
(III) Penton base; (Ilia) Peripentonal area; (IV) Fiber* "3(X>lt" refers to 
a high MM band seen when PPV antigens were used for IP/SD8 PACE. PPV 
antigens were used for sera showing VS titers of j«16 and cell lysates 
were used for sera showing SN titers of ^ 32. 
R^esults of IP/SOS PACE between cell lysates and RJ54-IU59 (data 
not shown), from gels different than ones shown in Figures 3 and 4, were 
used in these designations. 
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Procipicin Rabbit Homologous , 
lin#* No. VK eiesr Polypcptidas bound in IP/SDS PACE 
A RJ9 16 (3Q0K), 11, Xlla, IV 
B RJIO 256 11, 111, Ilia, IV 
A RJ17 <2 11 
B RJ13 <2 (300K), 11 
A RJIS <2 (3Q0K}. 11, IV (w«ak) 
B RJ19 <2 (300K), 11 
A RJ29 128 11 
B IU30 8 11 
A RJSl 4,096 11 
B RJ32 32 11, IV (weak) 
A IU33 256 11 
B IU34 4 (300K), II, IV 
C RJ35 16 II 
Single RJ36 4 (30010, II, III, Ilia, 
A RJ48 8 (300K). II 
B iU43 256 II, III, Ilia, IV 
C RJ42 1,024 II 
A iU54 <2 II, IV® 
B RJ55 16 11. IV® 
C RJS6 32 II. IV® 
D IU57 64 II c 
E IU58 2,048 II, III, Ilia, IV% 
P IU59 64 II, III, Ilia, IV® 
A IU60 2 (300K). II, IV (weak) 
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which aro probably aggragatas of haxona. All aneisara vara VK nagaciva 
to hatarologoua viruaaa, except for RJ13 and RJ19. RJ13 and RJ19 
ahowed VM titers of 64 and 16, respectively, against BAV-3. All pre-
inoculation sera were negative (j(2) to homologous and heterologous viruses. 
Monospecificity was determined by IP/SDS PACE (Figures 3 and 4). 
Monospecific Sera Against BAV-3 Subunits 
the various sera produced from immunising rabbits with agarose 
imaunoprecipitates of BAV-3 subunits are shown in Table 4. Eight anti-
sera were monospecific to hexons, with 4 of these having VN titers ^ 2S6. 
CIE and ID results, in addition to IP/SDS PACE results, were used to 
determine monospecificity because non-specific IP restions were evident 
(data not shown). All of the antisera were negative in heterologous VN 
reactions and none of the preinoculation sera showed homologous VN activity. 
Monospecific Sera Against BAV-7 Subunits 
The various sera produced from immunizing rabbits using immuno-
precipitates of BAV-7 subtmits are shown in Table 5. Four monospecific 
sera were obtained. While all four showed VN titers of ^64, 2 were 
precipitating and 2 were non-precipitating in CIE and ID reactions. 
Monospecificities of RJ26 and iU27 were determined by IP/SDS PAGE (data 
not shown). An antiserum having no anti-hexon specificity was obtained; 
similar sera were not obtained from BAV-2 and -3. This serum, BJ14, was 
reactive to the pentonal polypeptides such as pentoo base, peripentonal 
area and fiber. All antisera were negative in heterologous VN tests and 
Figura 3. Hooologous XP/SDS PACE results of rtsccions bstvsan VN 
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positive (citer 02) antisera and ( S]-methionine labeled 
BAV-2 cell lysates. Rexon, penton base, peripentonal area 
and fiber correspond to polypeptides II, III, Ilia, and IV, 
respectively, according to standard adenovirus SDS PACE 
nomenclature 
figure 4. Hooologous IP/SOS PACE results of reactions between VN 
negative (titers J^ 16) antisera and {^'s)-oetbionine labeled 
BAV-2 PPV antigens. Bexon and fiber correspond to poly­
peptides 11 and IV, respectively, according to standard 
adenovirus SDS PACE nooenclature 
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Table 4. VN ticsrs and probable apaclficitiaa of rabbit antisara 
produced from immunoprecipitatea of BAV-3 aubunita 
Antigen Intermediate Method of 
Gel no. preparation Antibody gel antibody separation 
1 Kexona RJ4 - LIE 
2 SAS/NEM RJ5 - LIE 
3 Kexona RJS - LIE 
4 SAS/HEM RJ6 - LIE 
i SAS/Sucrose RJ6 . LIE 
6 SAS/NEN RJS RJ24 LIE 
7 Cell lysates iU39 - LIE 
8 Cell lysates iU39 - LIE 
P^recipitin lines in LIE were lettered from the anodic side of gel. 
O^nly reactions to hexons and fibers were determined from IP/SOS 
PACE due to the presence of non-specific reation*. Monospecificity was 
determined with the aid of CIE and ID patterns (data not shown). 
Specificities to penton base and peripentonal polypeptides may be present 
in m*y of the sera. In addition, more than one electrophoretic species 
may be present in CIE. 
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Precipitin Rabbit Koiaologoua . 
line* no. VK titer Probable specificities 
A RJ5 32 hexons 
B RJ6 256 hexons. fibers 
A RJ20 8 hexons 
B RJ21 <2 hexons 
A RJ22 256 hexons 
B RJ23 96 hexons. fibers 
A RJ24 256 hexons 
B IU28 <2 hexons 
Single RJ2S 32 hexons. fibers 
A IU37 1.024 hexons 
B IU38 1.024 hexons 
A RJ49 1.024 hexons. fibers 
B RJSO 1,024 hexons. fibers 
C IU51 1,024 hexons. fibers 
A IU52 1,024 hexons. fibers 
B RJ)3 1,024 hexons. fibers 
Tabic S. VN Citer# and probable specificities of rabbit antisera 
produced from immunoprecipitates of BAV-7 subunits 
Antigen IntervMdiate Methods of 
Gel no. preparation Antibody gel antibody separation 
1 PPV C72 - CIE 
2 PPV*^  RJl - LIE 
3 PPV** RJl - CIE 
4 PPV^  RJl - CIE 
5 PPV RJ8 - LIE 
6 SAS/MEM C72 RJll LIE 
P^recipitin arcs in CIE were numbered from the cathodic side of 
the gel while precipitin lines in LIE were lettered from the anodic side. 
D^ue to difficulties in obtaining sufficient quantities of labeled 
or non-labeled BAV-7 antigens» a combination of methods were used, in 
addition to IP/SDS PAGE, to determine the specificities of the sera. 
Standard adenovirus SOS PAGE nomenclature was used: (II) Hexon; (III) 
Penton base; (Ilia) Peripentonal area; (IV) Fiber. 
T^hese specificities were determined by Western blot analysis. 
P^V antigens were treated with 0.5% deoxycholate and beat (56®C, 
3 minutes). 
N^ot determined. 
R^J14 did not react to hexons in IP/SDS PAGE, but was reactive to 
the other major polypeptides. 
S^Jll and BJ12 were obtained from a different commercial source from 
RJ15 and RJ16. Identical immunoprecipitates were used in the correspond­
ing rabbits. 
1^1 and BJ12 were monospecific, as determined by CIE and ID (data 
not shown). SJ26 and BJ27 reacted only to the hexon band in IP/SDS PAGE 
but they were nonprecipitating in CIE and ID. 
1 
2 
3 
A 
B 
1 
2 
3 
I 
2 
3 
A 
B 
A 
B 
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Homologous Probable . 
Rabbit no. Vti titer specificities 
RJl 256 11, iir 
IU2 512 11 and others 
RJ3 1,024 11, 111, 111a 
RJ7 32 N.D.* 
RJ8 4,096 11 and others 
IU14 
RJll 
<2, 
2,048* 
111, Ilia, IV 
Ïl5 
IU12 648 11** 
IU14 <2 III, llla, IV 
RJIS 168 8.0.® 
IU16 <28 N.P.# 
IU26 512 112 
RJ27 64 11** 
RJ46 128 II and others 
IU47 384 II and others 
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none of the prcinoculaelon icra shoved homologous VN activity. 
IP/SDS PACE Cross-reactions 
The results of IP/SDS PACE cross-reactions between the type-
specific reference sera and ( Sl-methionine labeled KAV-2, BAV-3 and 
BAV-2 cell lysates are shown in Figures 5, 6 and 7. reapectively. CCIO. 
an antiserum to strain 9639 <a probable subgroup 2 BAY type), was Included 
3S for comparisons with anti-BAV-7 serum. ( S)-Mthionine labeled BAV-7 
antigens were not available for this experiment. Mock-infected cell 
controls also were tested to Insure the validity of these reactions. The 
controls for BAV-2 and BAV-3 XP/SDS PAGE are shown in Figure 8. All other 
controls (data not shown) also were negative. Varying degrees of inter-
subgroups and intrasubgroup cross-reactions were evident for hexon. penton 
base* peripentonal area and fiber polypeptides. However» the homologous 
reactions of the fiber polypeptide remained the strongest, emphasizing the 
dominance of its type-specific determinants. Ko intersubgroup cross-
reaction was obtained between BAV subgroup 2 antisera (C72 and CCIO) and 
HAV-2 cell lysates for peripentonal area and fiber polypeptides. In fact, 
these two antisera showed a similar pattern (see Figure 5) that was distinct 
from BAV subgroup 1 antisera. The nonreactivities of ItJ4 and C72 to 
BAV-2 lysates (Figure 8) may have been caused by errors in measuring test 
reagents and should not be used as conclusive results. There were cross-
reactions for peripentonal polypeptides between BAV subgroup 2 antisera 
and BAV subgroup 1 viruses (BAV-2 and -3), as shown in Figures 6 and 7, 
Figure 5. XP/SDS PAGE of (^ S^l-nothionino labeled HAV-2 cell lyaaces 
reacted to type-specific reference sera. The homologous 
serum is rfl07. Autoradiography vaa performed for 16 hours 
at -70^ C. Molecular weights for HAV-2 capsid polypeptides 
were summarized in Tooze (31) 
Figure 6. 1P/8DS PACE of I^ S^)-m«thlonine labeled BAV-3 cell lysates 
reacted to type-specific reference sera. The homologous 
serum is RJ4, Autoradiography was performed for 16 hours 
at -70®C 
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Figure 7. IP/SOS PACE of [^ S^]-iMthionin« labeled BAV-2 cell lyaaces 
reacted to type-specific reference sera. The homologous 
serum was C87. Autoradiography was performed for 24 hours 
at -70°C 
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Figure 8. IP/SOS FACE of I Sl-methionine labeled BAV- and mock-
infected cell lysates and PFV. 087 is the reference 
serum for BAV-2. RJ4 and RJ39 are reference sera for 
BAV-3. Autoradiography was performed for 24 hours at 
-70®C, II: Bexon; III: Fenton base; Ilia: Feripentonal 
area; IV; Fiber 
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Peptide Analysis 
Since both viral neutralising and non-neutrallslng antlsera were 
obtained, peptide analysis using S. aureus V8 protease was performed on 
hexon bands cut out from SDS PACE gels, tto difference was detected 
between the hexon bands Immunopreclpltated by VH positive and negative 
sera (data not shown), using this particular enzyme and a one-dimensional 
gel. However, digests of slightly different molecular weights were 
obtained from hexon bands of HAV-2 and BAV-3 (see Figure 9). Varying 
degrees of reactions were also evident. For example, sera with high VN 
titers (RJ4 and RJ6) showed stronger reactions in comparison to RJS, which 
only has a VN titer of 32. However, the difference could be attributed to 
concentrations of test regents. 
Western Blot Analysis 
Western blots were performed to see if the antisera could react to 
sequential determinants, as in the case of bacterial fusion viral proteins 
produced using recombinant DNA technology. These preliminary results 
appear to indicate that the major polypeptides retained their immuncHr 
logical reactivities after the transfers. Western blots using BAV-7 FPV 
antigens and method 1 (BSA blocking), and BAV-3 cell lysates and method 2 
(Tween 20 blocking), are shown in Figures 10 and 11, respectively. Method 
2 was preferred over method 1 because some of the antisera reacted to 
BSA (data not shown), thus making interpretation of results impossible. 
RJ4 appeared to be able to react better with sequential determinants than 
the sera produced from agarose immunoprecipitates (Figure 11). As shown 
Figure 9. Peptide analysis of hexoo bands from IP/SOS PACE gels. Autoradiography 
was performed for 72 hours at -70®C 
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Figure 10. Western blot analysis of BAV-7 PPV antigens and various 
antisera. C72 is the reference serum; fUl - 3 are anti-
subunit sera. MRS: Normal rabbit serum. ttCS: Normal 
calf serum. JWt Human control serim. C225: Control calf 
serum. Autoradiography was performed for 17 hours at 
-70®C (with screen) 
Figure 11. Western blot analysis of BAV-3 cell lysate# reacted 
to various BAV-3 antisera. Autoradiography was 
performed for 12 hours at -70*C (with screen) 
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in Figuras 10 and 11, eha capsid polypapcidas ramainad réactiva after 
transfer. However, the reactions to hexons were weaker than expected. 
Molecular Weights of BAVs 
The apparent molecular weights of BAV-2, -3 and -7 were determined 
by SDS PACE. The MWs of the four major capsid polypeptides <11, 111, 
XXXa, XV), along with published values, are shown in Table 6. 
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Table 6. The apparent molecular weights for BAV-2, -3 and -7 as 
determined by SDS PACE 
Apparent molecular weights* 
Polypeptide HAV-2^  BAV-2 BAV-3 BAV-3® BAV-7 
(published) 
1%** 120K lOSK llOK 113K lOOK 
III* 6SK 9SK 75K 68K 75K 
Ilia* 66K' 82K 6SK 64K 30K 
IV** 62K* 68K 6GK 52K 45K^  
M^olecular weights are expressed as kilodaltons and represent 
averaged values from five gels. 
*Ws of KAV-2 polypeptides were taken from Tooze (31). MWs of 
polypeptides 11, 111 and IV were published by Maizel et al. (22) and 
MW of polypeptide Ilia was published by Cveritt et al. (10). 
M^Ws of BAV-3 were published by Niiyama et al. (25). 
1^1: Bexon polypeptides. 
*111; Penton base polypeptides. 
*IIIa: Peripentonal area polypeptides (associated with peripentonal 
hexons). 
T^he apparent MM for Ilia of 8AV-2 was about 75K in the present 
study. 
**IV: Piber polypeptides. 
T^he apparent KW for IV of HAV-2 was about 70K in the present 
study. 
T^he values for III, Ilia and IV of BAV-7 was calculated using only 
one gel. 
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DISCUSSION 
Agaroi* inmunoalactrophorssis appaartd to ba a aufflclant mathod 
for iaolatin* aubunita that ara praiant In larga quantitlaa» auch aa 
haxona. The major problem encountered in line immunoelectrophoreaia 
vaa the difficulty in obtaining homogeneoua aamplea from a aingle pre­
cipitin line. Croaaed immunoelectrophoreaia appeared to provide better 
aeparation of aubunita aince it ia a tvo-dimenaional immunoelectrophoretic 
ayatem. For example, aubunita devoid of hexona were only obtained for 
BAV-7 uaing CIC. Xf theaa pentonal aubunita have electrophoretic 
mobilitiea different from the h«xon aubunita, they will be aeparated well 
from each other. On the other hand, the relative poaition of a precipitin 
line in LIE la determined by the antigen/antibody ratio and on occaaion 
different precipitin lines can superimpose on each other (18). This 
problem is compounded by the presence of hexon aubunits having different 
electrophoretic mobilities (4). This may be one explanation of why so 
mai^  agarose immunoprecipitstes contained hexon subunits (see tables 3-5), 
A better approach would bs to use LIE as a crude method only» to separate 
the subunits, and then further purify the antisera obtained from LIE 
using CZE. 
The antiserum produced from deoxycholate and beat created hexon 
subunits, BJ4, appeared Co be superior to the sera produced from agarose 
ioaunoprecipicaces in the following ways. It reacted beccer in Wescem 
bloc analysis (see Figure 11), thus making ic a good reagenC in testing 
cloned viral polypeptides prepared as bacterial fusion produces. EJ4 
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is viral nautraliting, making these subunits possible candidates for 
subunit vaccine antigens. In addition, these subunits were capable of 
inducing both subgroup- and type-specific viral neutralising antibodies 
(see Table 2), making then ideal candidates for multivalent subunit 
vaccines. 
The molecular weights obtained for BAV-3 appear to be in agreement 
with previously published values (25). The major difference was the 
higher molecular weight estimated for fiber (see Table 6). While the 
molecular weights of the hexons appear to be similar for the three BAV 
serotypes, the molecular weights of the other capsid polypeptides differ 
significantly. The peripentonal area and fiber polypeptides appeared to 
be the owst variable. The apparent molecular weights for the peripentonal 
area polypeptides are 82K, 65K and SOK for BAV-2, -3 and -7. respectively. 
Fiber polypeptide molecular weights are 68K, 60K and 45K for BAV-2, -3 
and -7. respectively. Only BAV-3 showed similar molecular weights to 
BAV-2 for these two polypeptides. The apparent molecular weights for 
penton bases are similar for BAV-3 and -7. The molecular weights of 
polypeptides III, 111a and IV for BAV-2 are significantly higher than 
values obtained for HAV-2 and the other two BAVs. 
It is believed that each adenovirus serotype displays an unique 
molecular weight pattern for polypeptides II, III, Ilia and IV (34). In 
addition, the size of the fibers (37), and to some extent, the sizes of 
hexons and penton bases (34) have been used in subgroup classification 
of HAVs. Additional studies are needed on the molecular weight patterns 
of BAVs. Together with genomic homology data, it may be possible to 
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d«vlflc a mora daeailad BAV subgroup classification schema than the 
present two-subgroup system. 
The capsld antigens involved in neutraliiation are primarily those 
associated with hexon, but fiber antigens also have been implicated (37). 
Since hexon subunits are abundant and can be easily isolated (S), they 
make good candidates for subunit antigens. The abilities of the hexon 
subunits isolated in this study to induce protective responses in calves 
need to be tested in vaccination/challenge studies. 
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PART IX. GENOMIC HOMOLOGY BETWEEN BOVINE ADENOVIRUS TYPE 7 
AND HUMAN ADENOVIRUS TYPE 2 
This manuscript has bean published as a part of another namiscrlpt 
in the Journal of Virology, 
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ABSTRACT 
Unlika note adtnovirusas iaolaead froa mammalian hoata, bovina 
adanovirua typa 7 (BAV-7), a mambar of BAY lubgroup 2, doaa not ihara 
the group-ipacific conplamant-fixation antigen trith human adanovirua 
type 2 (KAV-2). In order to locate the genes coding for the major capaid 
proteina on the BAV-7 genome and to atudy poaaible evolutionary relation-
ehipa between the viruaea, croaa-hybridiaation atudiea were performed 
on viral DKAs uaing cloned reatriction fragmenta aa probea, Conaiatent 
with the imoMnological obaervationa, no hybridization was detected under 
normal conditiona (annealing in IM NaCl at 65^ C and washing in 0.4N 
NaCl at 65**C). However* at reduced atringeney (annealing and waahing in 
IM NaCl at )7^ C), two distinct regions of homology were observed. One 
such region centered around 10.3 to IS.S map units (a.u.) on the HAV-2 
genome, corresponding to the lVa2 protein gene. Jhe other region lay 
between 41 to 70 a.u. on HAV-2, with the nwst conserved region (50.1* 
58.5 n.u.) coding for the major capaid protein* hexon. These results 
allow the alignment of the two genomes. Furthermore* the present results 
are in contrast to the earlier observation that extensive homology exists 
between HAVs and BAV-3, which is a member of a different BAV subgroup. 
Taken together, these results strengthen the classification of these two 
bovine adenoviruses into separate subgroups* and lend support to the notion 
that subgroup differentiation of adenoviruses occurred before or shortly 
after the speciation of the hosts. 
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INTRODUCTION 
Bovine adenovirus type 7 (BAV-7) hes been ieoleted fron calves 
with pneusicentericis (11,16,22), weak calf syndrome (3,17,26), and from 
bovine testicular cultures as an adventitious agent (21). In addition. 
BAV-7 has been reported to cause abortion experimentally (25). 
Being a member of BAV subgroup 2, BAV-7 does not share the common 
soluble complement-fixation antigen with other mammalian adenoviruses 
such as human adenoviruses (HAVs) and BAV subgroup 1 viruses (2). BAV-7 
was identified as an adenovirus based on its morpholoRf, nature of nucleic 
acid content, and other physiochemical properties such as resistance to 
ether and chloroform (11). 
The genome of BAV-7, including restriction mapping, has been studied 
(8). The size of its genome was estimated to be 29.35 ± 0.8 kilobase 
pairs (8), which is considerably smaller than those of RAV-2 (27) and 
BAV-3 (12), and is closer to that of murine adenoviruses Ft (13). 
Genomic homology studies between different adenoviruses, besides 
providing valuable insights into their evolutionary relationships, can 
contribute to the development of a more rational approach to virus 
taxonwy (1). Genomic homology studies have been performed between BAV 
serotypes (5,6,7), and between HAVs and conventional mammalian adeno­
viruses of animal origin such as BAV-3 (9,18) and murine adenovirus FL 
(13). In addition, homology studies also have been performed between 
avian and human adenoviruses (1). Although these viruses do not cross-
react serologically, regions of homology were observed between their 
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genotMS (1). 
The objactivas of this study war* Co locaca tha ralatlva positions 
of tha ganas coding for tha major capsid protains on tha BAV-7 ganoma 
by alignnant to tha KAV-2 ganoma, and to study possible evolutionary 
relationships between human and bovine adenoviruses. 
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MATERIALS AND METHODS 
Eniystts and Reagents 
Restriction endonucleaaes Bgi II, Eco RI, Kind III, Kpa I, Kpn I, 
Sac I, Sna I, and Xho I were purchased Item New England Biolabs 
(Beverly, MA). DNase I and DNA polymerase I (E. coll) were purchased 
32 from Bethesda Research Lab. (Calthersburg, KD). Pj-labeled 
deoxynucleoside triphosphates were prepared at Molecular Genetics, Inc. 
(45 uCl/ul, used at 1 ul per O.S ug of DNA). All enzymatic reactions 
were performed under conditions specified by the manufacturer, unless 
otherwise Indicated. 
Viral DNA 
BAY-7 (strain Fukoroi) was propagated on low passage bovine embryonic 
testicular (BET) cells. BAV-3 (strain WBR-1) was propagated on KeLa cells. 
Cell cultures were grown in Dulbecco modified Eagle's minimum essential 
medium (D-MEM) supplemented with 10% fetal bovine serum, 100 l.U. per ml 
of penicillin, and 100 ug per ml of streptomycin sulfate. Cultures were 
infected at a multiplicity of 0.01 plaque forming units (PFV) per cell, 
maintained in D-MEM supplemented with 2% globulin-free calf serum, and 
harvested at 48 hours postinfection. Viral DNA was prepared from cesium 
chloride (CsCl) gradient-purified virions as described by Pettersson 
and Sambrook (20). 
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Plaanid Clones 
FragBMnts of viral DMAs gonsraead by rastricclon aniynas vara 
insarcad inco baeearial plaamids (pBR322) and cloned using standard 
cloning procedures (@,9,10,15). The plasmid clones chosen for this study 
were the Kind 1X1 clones of KAV-2 (10), Che Kind 111 and Eco RI clones 
of BAV-7 (8), and the Hind 1X1 and Eco RX clonea of BAV-3 (9). 
Agarose Gel Electrophoresis 
Restriction endonucleaae frapuents of viral DKA were separated on 
IS or 1.4% horizontal agarose (SeaKen ME, FMC Corp.. Marine Colloids 
Div., Rockland, ME) slab gels in loening's buffer.* Electrophoresis was 
performed at 2.5 V/cn for 16 hours. The DMA bands were stained with 
ethidium bromide and visualized with UV illumination. 
Purification of Cloned DMA Fragments 
The M(A of plasmid clones was purified from ethidium bromide-CsCl 
gradients using standard methods (15). cut with the respective restriction 
endonuclease. and separated by agarose gel electrophoresis. The DNA 
digests were separated either in a 1% SeaKem agarose gel as described 
above, or in a 12 lowmelting-temperature (UfT) agarose (Sea Plaque. 
2 
FMC Corp.) gel using E buffer. The agarose bands containing the DKA 
L^oening'e buffer is 0.36 M Tris, 30 mM NaHgPO^ .HgO and I mM Na^  EDTA. 
buffer is 40 mM Tris-HCl, pH 8.0, 1 mM EDTA and 5 id( Sodiim acetate. 
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inacres ware cut out from the stained gels upon UV illumination. The 
DMA waa recovered from the agaroae uaing one of the following methoda. 
Method 1, 
OKA in SeaKem agaroae waa electroeluted at 10 V/cm for 3 houra in 
0.5% TBS buffer.^  followed by purification on DEAE-Sephacel (Pharmacia 
Fine Chen., Piacataway, NJ), aa deacribed by Maniatia et al. (15). 
Method 2 
DNA in LMT agarose was recovered by melting at 65*C for 10 minutea, 
followed by standard DMA purification procedures, as described by 
Maniatis et al. (15). 
Subcuts of Purified Cloned OKA Fragments 
Restriction endonuclease digests of cloned DNA fragments were 
separated on 1.2% or 1,5% SeaKem agarose gels as described for viral DNA. 
The HAV-2 fragments chosen for analysis were Hind %II-A, -B, -C and -D. 
Wind Ill-A fragment was cut with Eco Rl, Kpn I or Sma 1. Hind III-B 
fragment was cut with Kpa 1. Sma I or Xho I. Hind III-C fragment was 
cut with Bgl II, Sac I, Sma I, or Xho I. Hind III-D fragment was cut 
with Kpn I. 
1^ X TBB is 90 mM Tris, 8.9 mM Boric Acid, and 2 mM Na^ EDTA. 
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Transfer of DMA 
DKA fragments were transferred from agarose gels to nitrocellulose 
filters essentially as described by Southern (24). After electrophoresis, 
the DMA in the gel was denatured by soaking in 0.2M NaOM and 0.6M NaCl 
for 45 minutes, followed by neutralisation in IM Tris-HCl, pH 7.4 and 
0.6M NaCl for the same duration. The transfer was performed for 16 hours 
in 6XSSC.* Filters were air-dried, baked at 80*C under vacuum for 2 hours, 
and cut into strips before hybridization. 
Hybridization Conditions 
TVo sets of hybridization conditions were employed. For normal 
stringency, annealing was carried out in 6XSSC at 65°C. followed by washing 
in 2XSSC at the same temperature. For reduced stringency, both annealing 
and washing were done in 6XSSC at 57°C. Normal stringency was used for 
all homologous hybridizations, and for heterologous hybridizations between 
BAY-3 and HAV-2. Reduced stringency was used for all other heterologous 
hybridizations. 
The filter strips were prehybridized for 2-4 hours in 6XSSC and 
0.2% each of bovine serum albumin, Ficoll and polyvinylpyrrolidone. 
Bybridization buffer was the same with the addition of 0.5% SOS, 1 mM ESTA 
and 0.125 ug of denatured probe. Probes of either viral DMA or cloned 
32 
DSA fragments were radiolabeled ^  vitro with Pj-deo*ynucleoside 
I^XSSC is 0.15M NaCl and 0.015M Sodium citrate. Both 6X and 2XSSC 
solutions were diluted from a 20X stock, which is 175.3 g/1 of NaCl and 
88.2 g/1 of Sodium citrate. 
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eriphosphacas uaing nick-translation (23). Hybridizations wore carried 
out lor 16 hours. The hybridized filters were washed three times, air-
dried and mounted for autoradiography. 
Restriction Maps 
Reference restriction maps for HAV-2, BAV-3 and BAV-7 were published 
by Tooze (27), Kurokava et al. (12) and Hu et al. (8), respectively. 
The base pair (bp) equivalents per map unit (m.u.) for HAV-2. BAV-3 and 
BAV-7 are 339 bp/m.u., 350 bp/n.u. and 293.5 bp/n.u., respectively. 
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RESULTS 
Croft-hybridlxatlons Between BAV-7 and RAV-2 
Under normal condition#, no homology was detected between BAV-7 
and HAV-2 (data not ihown). However» at reduced stringency, homology 
was detected between the two vlruaee. 
Experiment ^  
Figure 1 ihowa the reeulte when HAV-2 Sma 1 digests were transferred 
to filters and hybridized to nick-translated BAV-7 Hind 111 and Eco R1 
clones. Two regions of homology were detected between BAV-7 Hind lll-B, 
-C, -F, Eco RI-C, -Oj, -C clones and HAV-2 Sna I-F, -B, -D, -H, -A 
fragments. 
Experiment 2 
Figure 2 shows the results when BAV-7 Eco RX digests were transferred 
to filters and hybridized to nick-translated HAV-2 Hind 111 clones. 
(Results of using BAV-3 probes are described in a later section.) 
Basically, two regions of homology were observed between the two viruses, 
as in experiment 1. On the BAV-7 genome, these regions were located at 
9.31-19.46 m.u. and 50.1-57.6 m.u., corresponding to 7.9-37.3 m.u. and 
50.1-73.6 m.u. on the HAV-2 genome. 
Experiment 3 
To obtain finer boundaries within the 2 regions of homology, selected 
HAV-2 Hind XIX clones were cut further with various restriction 
Figura 1. HAV-2 Sma t digests hybridized to nick-translated BAV-7 
clones. The first lane is the homologous hybridization 
using nick-translated HAV-2 probe. Autoradiograph is 
shown in the insert 
Figure 2. BAV-7 Eco RI digests hybridized to nick-translated HAV-2 
and BAV-3 clones. Th« first lane is the homologous 
hybridization using nick-translated BAV-7 probe. Auto­
radiograph is shown in the insert 
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endonucleases, and hybridized to selected nick-translated BAV-7 Hind 111 
clones. As shown in Figures 3 and 4, subcuts of HAV-2 Hind III-C, -B, 
-D and -A clones were hybridized to BAV-7 Hind 111-B, -F, and -C probes. 
Cross-hybridizations Between BAV-7 and BAV-3 
No homology was detected between BAV-7 and BAV-3 under normal condi­
tions (data not shown). However, under reduced stringency, homology was 
detected between the two viruses. 
Experiment _l 
Figure 2 shows the results of BAV-7 Eco R1 filters hybridized to 
selected BAV-3 Eco RI and Hind 111 probes. Two regions of homology were 
evident. The first region was located at 9.31-19.46 n.u. on BAV-7 genome, 
corresponding to 5-11.9 m.u. on BAV-3. The other region centered around 
SO.1-57.6 m.u. on BAV-7 genome, corresponding to 44.3-62.7 m.u. on BAV-3. 
Experiment 2 
Figure 5 shows the results when BAV-3 Eco RI and Bind III digests were 
transferred to filters and hybridized to nick-translated BAV-7 Hind III 
clones. Again, two regions of homology were detected between the 2 viruses. 
Composite Results 
From the above experiments, the limits of genomic homology were de­
fined, as shown in Figure 6. Between BAV-7 and HAV-2, one region of 
homology centered at 9.4 to 28.1 m.u. on HAV-2 genome, with the strongest 
Figura 3. Aucoradiographa of HAV-2 Hind 111 clonea digaata 
hybridized co BAV-7 clonea 
figure 4. Subcuea of HAV-2 Hind XIX clonea hybridized co nick-
tranalaeed BAV-7 clonea 
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Figure 6, Summary of results of cross-hybridtsattoos between BAV-7 and classical lunaallan 
adenoviruses (HAV-2 and 8AV-3). The locations of the WAV-2 bexon, lVa2 and IX 
protein genes are shown 
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hybridization at 10.3-15.5 n.u. (the lVa2 protein gene). The correspond­
ing region on BAV-7 was located at 9.31 to 19.46 m.u. The other region 
of homology centered at 41 to 70.7 m.u. on HAV-2, with the strongest 
hybridization at 50.1-58.5 m.u. (the hexon protein gene). The correspond­
ing region on the BAV-7 genome was 39.72-57.6 n.u. By aligning the BAV-7 
genome to that of RAV-2, the locations for the hexon and XVa2 genes for 
BAV-7 were deduced as 50.1-57.6 m.u. and 9.31-17.82 m.u., respectively. 
Between BAV-7 and BAV-3, one region of homology centered at 5-19.4 n.u. 
on BAV-3 and 9.31-19.46 m.u. on BAV-7. The other region lay between 53.8-
59.9 m.u. on BAV-3, corresponding to 50.1-57.6 m.u. on BAV-7. 
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DISCUSSION 
In eontrase to immunological data, ganomic homology waa datactad 
batvaan BAV-7 and KAV-2. Aa axpactad, homology waa datactad in tha 
haxon-coding region. Sinca attuctural conatrainta dictate certain 
ainllaritlaa in the amino acid sequences of the hexon proteins from 
different adenoviruses (9), at least part of the hexon gene would be 
expected to be conserved in order to generate a capsid protein that gives 
rise to the characteristic adenovirus architecture (1). 
The other region of homology waa detected in the lVa2 gene. This 
protein is believed to be a scaffolding protein Involved in virion assembly 
(4,19). Since the lVa2 protein interacts with hexons, it is expected to 
be highly conserved among adenoviruses (8). The location of the hexon and 
lVa2 genes allowed the alignment of the BAV-7 genome to that of HAV-2. 
Previous studies have Indicated that extensive homology exists 
between BAV-3 and EAV-2 (8), and limited hoowlogy exists (in two distinct 
regions) between mouse adenovirus FL and BAV-2 (13), under standard 
conditions. Since the homology between BAV-7 and HAV-2 was detected only 
at reduced stringency, these results indicated that, of the three animal 
adenoviruses, BAV-7 was related most distantly to RAV-2, followed In that 
order by the murine adenovirus and BAV-3. 
It is noteworthy that limited homology was observed between HAV-2 
and CELO virus (1), an avian adenovirus which also does not possess the 
mammalian group-specific complen^ nt-fixation antigen. It seems that this 
virus would be more removed evolutionary from HAV-2 than BAV-7. 
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Homology «eudias among BAVs and batvaan BAVs and HAVs ara naadad to 
obtain a battar classification systam for BAVs. Many of tha subgroup 2 
BAVs hava not baan atudiad adequately due to the absence of the complement-
fixation group-specific antigen. These results indicate that BAVs can be 
studied using genomic homology studies instead of immunologic criteria. 
Since previous studies (9,18) hava indicated that extenaive homology 
exist# between HAVs and BAV-3, the present study strengthens the classifi­
cation of BAV-3 and BAV-7 into two separata subgroups. In addition, it 
lends support to tha notion that the aubgroup differentiation of adeno­
viruses occurred before or shortly after the speciation of the hosts (28). 
90 
ACKNOWLEDGEMENTS 
W« chank ch« parionnal at MCI for madia preparations. Special 
thanks go to Ms. Diane Potts for her excellent technical assistance 
and Ms. Judith Wheeler for her critical review of the manuscript. This 
work was supported by and performed at Molecular Genetics, Inc. 
91 
REFERENCES 
1. P., A, Stanlundf P. Li, A. and U. Patcaraton. 
1982. Saquanca homology batwaan avian and human adanoviruaaa* 
J. Virol. 42*306-310. 
2. Bartha, A. 1969, Proposal for auhjrouping of bovina adanoviruaaa. 
Acta Vat. Acad. Sci. Hung. 19*319-321. 
3. Coria, M. F., A. U. MeClurkin, R. C. Cutlip, and A. E. Ritchia. 
1975. Isolation and charactariaation of adanovinia typa 5 
aaaociatad with waak calf syndroms. Arch. Virol. 47*309-317. 
4. O'Halluin, J.-C., C. R. Martin, G. Torpiar, and P. A. Buulangar. 
1978. Adanovirua type 2 aasambly analyaad by ravarsibla cros^  
linking of labile intermediates. J. Virol, 26*357-363. 
5. Caron, C. F., K, W. Berry, J. C, Hierholser, and J, A. Roae. 1973. 
Mapping of baae sequence heterologies between genomes from different 
adenovirus serotypes. Virology 54*414-426, 
6. Green, M, 1970, Oncogenic Viruses, A*m, Rev, Biochen, 39*701-756. 
7. Green, M., J, K, Mackey, W, 8, M, Wold, and P, Rigden, 1979, 
Thirty-one human adenovirus serotypes (Ad 1 and Ad 31) from five 
groups (A - E) based upon DHA genome homologies. Virology 93* 
481-492, 
8. Htt, S,-L,, J, K, Battles, and D, E, Potts, 1984, Restriction analysis 
and homology studies of the bovine adenovirus 7 genome, J, Virol. 
51*880-883, 
9. Ot, S,-L,, W, W, Bays, and D, E, Potts. 1984, Sequence homology 
between bovine and hwoan adenoviruses, J, Virol, 49*604-608, 
10, Hu, S,-L,, and J, L, Manley, 1981, DMA sequence required for 
initiation of transcription in vitro from the major late promoter 
of adenovirus 2, Proc, Natl. Acad, Scl, 78*820-824, 
11, Inaba, Y, Tanaka, K, Sato, B, Ito, Y, Ito, T. Omori, and H. 
Matumoto, 1968, Bovine a^ novlrus, II, A serotype Fukurol, 
recovered from Japanese cattle. Jpn, J, Microbiol, 12*219-229, 
12. 
13. 
14. 
13. 
16. 
17. 
18 
19 
20 
21 
22 
92 
Kurokawa, T.» K. Igarashi, and Y. Sugino. 1978. Biochemical 
•tudias on bovine adenovirus type 3. III. Cleavage maps of viral 
DKA by restriction endonucleases Eco RI, Bam HI and Hind III. 
J. Virol. 28:212-218. 
Larsen, S. H., R. F. Hargoskee, and D. Nathans. 1979. Alignment 
of the restriction map of mouse adenovirus FL with that of 
human adenovirus 2. Virology 97:406-414. 
Laraen, S. H., and D. Nathans. 1977. Mouse adenovirus: Growth 
of plaque-purified FL virua in cell lines and characterization 
of viral ONA. Virology 82:182-183. 
Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular 
cloning. (A laboratory manual.) Cold Spring Harbor Laboratory. 
Cold Spring Harbor, N Y. 343 pp. 
Matwoto, H., Y. Inaba, Y. Tanaka, K. Sato, H. Ito, and T. Oowri. 
1970. New serotype 7 of bovine adenovirus. Jpn. J. Microbiol. 
14:430-431. 
McClurkin, A. W., and N. F. Coria. 1973. Infectivity of bovine 
adenovirus type 3 recovered from a polyarthritic calf with weak 
calf syndrome. J. Am. Vet, Med. Assoc. 167:139-141. 
Niiyama, Y., K, Igarashi, K. Tsukamoto, T. Kurokawa, and Y. Sugino. 
1973. Biochemical studies on bovine adenovirus type 3. I. 
Purification and properties. J. Virol. 16:621-633. 
Persson, H., B. Mathisen, L. Philipson, and U. Pettersson. 1979, 
A maturation protein in adenovirus morphogenesis. Virology 
93:198-208. 
Pettersson, U., and J. Sambrook. 1973. The amount of viral DMA 
in the «enome of cells transformed by adenovirus type 2. 
J, Mol. Biol. 73:123-130. 
Phillip, J. I. H., and J. J. Sands. 1972. The isolation of bovine 
adenovirus serotypes 4 and 7 in Britain. Res. Vet. Sci. 13: 
386-387. 
Seed, D. E., J. G. Wheeler, and H. W. iupton. 1978. Isolation of 
bovine adenovirus type 7 from calves with pneumonia and enteritis. 
Am, J. Vet. Res. 39:1968-1971. 
Rigby, P. W. J., H. Dieckaann, C. Rhodes, and P. Berg. 1977. 
Labeling deoxyribonucleic acid to high specific activity vitro 
by nick translation with DKA polymerase I. J. Mol. Biol. 113: 
237-251. 
93 
24. Southern, E. M. 1975. Detection of specific sequences among 
DHA fragmenta aaparatad by gel electrophoreaia. J. Hoi. Biol. 
98:503-517. 
25. Stauber, E., and C. Card. 1978.Experimental intraamnionic exposure 
of bovine fetuaea with aubgroup 2, type 7 adenovirua. Can. J. 
Comp. Med. 42:466-472. 
26. Stauber, E., H. W. Renshaw, C. Boro, D. Mattson, and F. W. Frank. 
1976. Isolation of a aubgroup two adenovirus from calf with 
weak calf ayndrome. Can. J. Comp. Med. 40:98-103. 
27. Tooze, J. (ed). 1980. Molecular biology of tumor viruaea. 2nd ed. 
Part 2. DMA tumor viruaea. Cold Spring Harbor Laboratory, 
Cold Spring Harbor, H.Y. 958 pp. 
28. Wadell, C., M.-L. Hammarakjold, G. Winberg, T. M. Varsanyl, and 
C. Sundell. 1980. Genetic variability of adenoviruses. Ann. 
R.Y. Acad. Sci. 354:16-42. 
94 
SUMMARY AND CONCLUSIONS 
Monospaciflc sara against protein aubunits of BAY types 2, 3 and 
7 were produced in rabbits using agarose inmunoprecipitates prepared 
by preparative line or crossed immunoelectrophoresis with hyperimune 
type-specific sera. Monospecific anti-hexon sera that were viral 
neutralising were obtained against all three serotypes. The sera pro­
duced were characterized by VN, XP/SOS PAGE, immunoelectrophoresis, 
immunodiffusion, and Western blot analysis. An anti-hexon subunit 
serum also was produced using deoxycholate and heat treatment followed 
by DEAE ion-exchange column purification. An attempt was made to analyze 
the differences between hexon subunits capable of inducing a viral 
neutralizing response and those that did not. 
Genomic homology studies were performed between BAV-7 and conventional 
mammalian adenoviruses (HAV-2 and BAV-3). Under reduced stringency, two 
regions of homology were detected between BAV-7 and each of the two viruses. 
These results allowed the alignment of the BAV-7 genome to that of BAV-2 
and the analysis of the evolutionary relationships among BAVs and HAV-2, 
The following conclusions may be made: 
1. Hexon subunits of BAV types 2, 3 and 7 are capable of inducing 
viral neutralizing responses in rabbits. 
2. Sequential determinants of hexon polypeptides can be recognized 
by anti-hexon subunits sera. 
3. Each of the 3 serotypes displays an unique molecular weight pattern 
for its major capsid polypeptides (II, III, Ilia, IV). 
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4. Two diteinct regions of homology exist between the genomes of 
BAV-7 and HAV-2 even though the 2 viruses do not cross-react 
iawinologically in complement-fixation tests. 
5» The classification of BAV-7 and BAV-3 into two different subgroups 
was strengthened by their differences in the degrees of genomic 
homology with HAV-2. 
Further research is needed in the following areas: 
1. Monoclonal antibodies need to be developed» which would allow 
further characterisation and purification of the hexon subunits. 
2. The differences in hexon subunits which induce neutralizing and 
now-neutralizing responses should be analyzed by epitope mapping 
using different enzymes and two-dimensional gel systems. 
3. Tha molecular weight patterns of all BAV serotypes, genomic 
homologies between these serotypes, and genomic homologies between 
the BAVs and HAV-2 should be studied In order to devise a more 
detailed subgroup classifieaelon of BAVs, 
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APPENDIXt REPRESENTATIVE IMMUNOELECTROPHORESIS AND IMMUNODIFTUSION 
RESULTS or BAV-2, -3, «\N0 -7 
Figure AL. Representative i#muneelectrephoreaie rewilts of BAV-2 subunits and antibodies 
Antigens: BAV-2 SAS/MEN antigens 
CIE: A to G 
Rocket: H to I 
Antibodies: (A) C87, reference antibody 
(8) RJ9 
(C) RJIO 
(D) €87 with RJ31 as an intermediate gel 
(fi) C67 with RJ32 (bottom) and RJ31 (top) as intermediate gels showing BJ32 and 
RJ3i reacting to different subunits 
(F) C87 with RJ42 as an intermediate gel 
(G) RJ42 with RJ31 as an intermediate gel showing both antibodies having the 
same specificities and RJ31 blocking out the subunit reactive to ILI42 
(H to J) Rocket patterns of RJ48, RJ43 and RJ42, respectively, showing antibodies 
frma rabbits immunised with 3 different immunwrecipitates from the same 
LIE gel 

Figure A2, CIE and ID patterns of BAV-3 antl#«w and monospecific antibodies 
CIE (A to G): SAS/HEN antigens 
ID (H to N) cell lysates antigens: (1) BAV-3; (2) lAV-2; (3) HeLa; (4) HDBK; (5) EAV-7: 
(6) HAV-2 
Antibodies: (A) &J4, reference antibody 
(B) &JS 
(C) ILI6 
(D) #U4 with HIS as an Intermediate gel 
(E) RJ4 with Rj6 as an intermediate gel 
(F) RJ4 with RJ24 as an intermediate gel 
(C) RJ4 with R121 as an intermediate gel 
(H) &J4 
(I) RJS 
(J) iU6 
(K) iU2l 
(L) &J24 
(M) IU37 
(N) RJ38 

Figure A3. Representative innunoelectro|^ ore«i8 re»ilts of BAV-7 subunits and antlbodles 
CIE; A to F, J and K 
LIE: G 
Rocket: H and I 
Antigens: (A) PPV, (8 to 0) DOC and heat treated PPV, (E to K) SAS/NDf antigens 
Antibodies: (A) C72, reference antibody 
Arcs 1, 2 and 3 were used to inoculate RJl, RJ2 and RJ3, respectively 
(B) RJl 
Arcs 1, 2 and 3 were used to inoculate RJ14, RJll and RJ12, respectively 
(C) RJ2 
(0) RJ3 
(E) RJll 
(F) RJ12 
(G) C72 with RJll M an intermediate gel 
Lines I and 2 were used to inoculate RJ46 and BJ47, respectively 
(H) RJ46 
(1) RJ47 
(J) RJll with RJ46 as an intermediate gel 
(K) RJll with RJ47 as an intermediate gel 
Ill 
